TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
MLYS

Mineralys Therapeutics, Inc.

Healthcare · Biotechnology

25.90$ -2.7% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

Mineralys Therapeutics, Inc. (MLYS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 668 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet MLYS
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
278 252 347 318 268 206 355 336 600 662 653 668
265 249 347 318 268 205 355 335 600 661 652 666
86 49 90 68 97 114 165 102 218 173 113 138
254 237 339 311 264 198 343 325 218 657 646 661
14 10 19 28 31 15 13 22 24 15 15 117
14 10 19 28 31 15 13 22 24 15 15 19
5.6 0.6 4.3 1.7 3.1 0.5 0.4 3.2 1.1 2.0 1.1 1.1
264 241 328 290 237 191 342 314 576 647 638 551
-100 -125 -156 -197 -254 -303 -345 -388 -425 -457 -497 -738
40 40 45 49 50 50 53 65 71 81 83 85

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?